cbdMD
Update in progressYCBD (NYSE American)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
cbdMD, Inc. develops and distributes hemp-derived CBD products in the U.S. and internationally. It owns and operates multiple brands, including cbdMD (oils, gummies, capsules, soft-gels, topicals, functional formulas, and hemp-derived Delta-9 products), Paw CBD (pets), ATRx (non-cannabinoid ingredients like functional mushrooms), and Herbal Oasis. Sold via direct-to-consumer, e-commerce, marketplaces, and wholesale. Based in Charlotte, NC; formerly Level Brands, renamed in 2019.
Company score
- Sentiment
- 0.27
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.06
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.16
- Governance
- 0.16
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.10
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.18
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE American (ASE)
- LocationUnited States
- CEOMr. T. Ronan Kennedy
- Employees42
- Websitewww.cbdmd.com
Identifiers
- ISINUS12482W1018
- FIGIBBG00J3H4KT7
- CUSIP12482W101
- CIK0001644903